Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 2
2008 1
2010 2
2011 5
2012 5
2013 7
2014 7
2015 5
2016 9
2017 4
2018 8
2019 5
2020 13
2021 16
2022 9
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.
Plett H, Ricciardi E, Vacaru V, Ramspott JP, Colombo N, Sehouli J, du Bois A, Garbi A, Richter R, Ataseven B, Aletti G, Braicu E, Heitz F, Portuesi R, Muallem MZ, Dagres T, Parma G, Roser E, Traut A, Multinu F, Harter P. Plett H, et al. Among authors: richter r. Int J Gynecol Cancer. 2023 May 1;33(5):734-740. doi: 10.1136/ijgc-2022-003854. Int J Gynecol Cancer. 2023. PMID: 36759002
Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ).
Chekerov R, Arndt T, Pietzner K, Canzler U, Wimberger P, Strauß HG, Mahner S, Woelber L, de Gregorio N, Stocker G, von Abel E, Neunhoeffer T, Belau AK, Mustea A, Yalinkaya I, Braicu EI, Richter R, Sehouli J; NOGGO ovarian cancer study group. Chekerov R, et al. Among authors: richter r. J Cancer Res Clin Oncol. 2023 Aug;149(10):7637-7649. doi: 10.1007/s00432-023-04647-9. Epub 2023 Mar 31. J Cancer Res Clin Oncol. 2023. PMID: 37000264 Free PMC article. Clinical Trial.
Patients' subjective assessment as a decisive predictor of malignancy in pelvic masses: results of a multicentric, prospective pelvic mass study.
Koch E, Torsten U, Mecke H, Richter R, Hellmeyer L, Nohe G, Müller B, Boeneß-Zaloum J, Ames K, Chen F, Beteta C, Hasenbein K, Pirmorady A, Zimmermann M, Dimitrova D, Tauber R, Sehouli J, Knieper CL, Ioana Braicu E. Koch E, et al. Among authors: richter r. J Psychosom Obstet Gynaecol. 2022 Sep;43(3):273-278. doi: 10.1080/0167482X.2020.1850684. Epub 2020 Nov 30. J Psychosom Obstet Gynaecol. 2022. PMID: 33252280
HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.
Braicu EI, Krause CL, Torsten U, Mecke H, Richter R, Hellmeyer L, Lanowska M, Müller B, Koch E, Boenneß-Zaloum J, Ames K, Chekerov R, Hasenbein K, Zimmermann M, Mangler M, Chen F, Tauber R, Sehouli J. Braicu EI, et al. Among authors: richter r. BMC Cancer. 2022 Jul 30;22(1):831. doi: 10.1186/s12885-022-09887-5. BMC Cancer. 2022. PMID: 35907794 Free PMC article.
90 results